Wells Fargo
HSCS icon

Wells Fargo’s Heart Test Laboratories HSCS Stock Holding History

Wells Fargo’s Portfolio HSCS Stock Details HSCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25
Closed -$63 – 7432
2026
Q1 		$63 Buy
+25
New +$73 ﹤0.01% 6560
2024
Q2 		– Sell
-5
Closed -$53 – 7138
2024
Q1 		$53 Buy
5
+4
+400% +$52 ﹤0.01% 6811
2023
Q4 		$11 Hold
1
– – ﹤0.01% 7365
2023
Q3 		$24 Buy
+1
New +$78 ﹤0.01% 7136
2023
Q2 		– Hold
0
– – – 7302
2023
Q1 		– Hold
0
– – – 7486
2022
Q4 		– Hold
0
– – – 7383
2022
Q3 		– Hold
0
– – – 6937

Other funds holding HSCS

TA
TFB Advisors Overland Park, Kansas $227M AUM 26.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ASW
Astoria Strategic Wealth Conroe, Texas $438M AUM 16.79% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TWM
Tradition Wealth Management Edina, Minnesota $1.64B AUM 26.59% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Wells Fargo's HSCS Position: Q2 2026 in Review

Wells Fargo sold out of Heart Test Laboratories (HSCS) in Q2 2026, closing a stake of 25 shares — an estimated $63 sold.

Wells Fargo first reported a position in HSCS in Q3 2023 and held it in 4 quarters. The position peaked at $63 in Q1 2026. 16 funds tracked by Wall St. Rank hold HSCS as of Q2 2026.

  • Wells Fargo reported no remaining Heart Test Laboratories position as of Q2 2026 after selling out during the quarter.
  • Wells Fargo sold 25 Heart Test Laboratories shares in Q2 2026, an estimated $63.
  • Wells Fargo first reported a position in Heart Test Laboratories in Q3 2023 and held it in 4 quarters.
  • Wells Fargo's Heart Test Laboratories position peaked at $63 in Q1 2026.
  • 16 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.